Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Diabetic Retinopathy
64%
Retinal Thickness
45%
Macular Edema
43%
Perifoveal Exudative Vascular Anomalous Complex
32%
Age-related Macular Degeneration
32%
Photodynamic Therapy
32%
Fundus Image
31%
Optical Coherence Tomography
24%
Subretinal Fluid
23%
Randomized Controlled Trial
23%
Diabetes Type 2
22%
Type 3 Neovascularization
21%
Fundus Image Registration
21%
Bevacizumab
21%
Multimodal Imaging
21%
Central Serous Chorioretinopathy
21%
Retinal Changes
21%
Proliferative Diabetic Retinopathy
21%
Bevacizumab Treatment
20%
Diabetic Retinopathy Screening
18%
Retinal Diseases
18%
Intravitreal Bevacizumab
17%
Retina
17%
Visual Acuity
17%
Best-corrected Visual Acuity
16%
Accuracy Assessment
16%
Grader
16%
Optical Coherence Tomography Angiography (OCT-A)
15%
Type 2 Diabetes Mellitus (T2DM)
15%
Retinal Layers
15%
Early Treatment Diabetic Retinopathy Study
14%
Proangiogenic Cells
14%
Treatment Effect
12%
Disease Progression
12%
Microaneurysms
12%
Retinopathy
12%
Retinal pigment Epithelium
12%
Illumination Variation
11%
Cystic Spaces
10%
Anatomical Changes
10%
Lipoproteins
10%
Phenotypic Characterization
10%
Mutation Detection
10%
Angiographic Characteristics
10%
Nonproliferative
10%
Short-term Response
10%
Red Lesions
10%
Quality Comparison
10%
Automated System
10%
Imaging Comparison
10%
Medicine and Dentistry
Diabetic Retinopathy
100%
Optical Coherence Tomography
63%
Macular Edema
41%
Maturity Onset Diabetes of the Young
37%
Central Serous Retinopathy
35%
Photodynamic Therapy
32%
Multimodal Imaging
23%
Optical Coherence Tomography Angiography
21%
Diabetes Mellitus
19%
Best Corrected Visual Acuity
18%
Morphology
13%
Angiogenesis
12%
Retinopathy
12%
Microaneurysm
12%
Retinal Pigment Epithelium
12%
Prednisolone
12%
Subretinal Fluid
11%
Patient Referral
11%
Lipoprotein
10%
Treatment Effect
10%
Image Registration
10%
Mosaicism
10%
Maculopathy
10%
Staphyloma
10%
Exudative Retinal Detachment
10%
Bevacizumab
10%
Moxifloxacin
10%
Multiple Myeloma
10%
Prednisolone Acetate
10%
Ophthalmoscopy
10%
Randomized Clinical Trial
10%
Iris
10%
Uveitis
10%
Disease Exacerbation
10%
Vascular Disease
10%
Transillumination
10%
Retina Disease
10%
Prevalence
10%
Telangiectasia
10%
Photochemotherapy
10%
Polypoidal Choroidal Vasculopathy
10%
Cohort Analysis
10%
Visual Acuity
9%
Surgical Anastomosis
8%
Microangiopathy
8%
Fundus Photography
8%
Eye Care
7%
Picture Archiving and Communication System (Medical Imaging)
7%
Retina Neovascularization
7%
Fluorescein Angiography
6%
